In a strategic move to bolster its leadership team, Redcare Pharmacy has announced the appointment of a seasoned e-commerce executive as its next Chief Financial Officer. The online pharmacy giant is bringing aboard Hendrik Krampe, whose extensive background includes senior financial roles at both Amazon and eBay, signaling a renewed focus on operational scaling and financial strategy.
E-commerce Expertise for European Expansion
Hendrik Krampe is set to assume the CFO position effective December 1, 2025, succeeding Jasper Eenhorst, who will be departing to pursue new professional opportunities. The supervisory board confirmed the appointment this Monday, with formal shareholder approval scheduled for the annual general meeting in April 2026.
Krampe brings more than two decades of financial management experience from some of the world’s most successful e-commerce corporations. His most recent eight-year tenure saw him serving as Finance Director for Amazon’s pan-European marketplace operations, a role he held since 2014. Previously, he spent ten years with eBay in various financial capacities across both German and American operations.
Should investors sell immediately? Or is it worth buying Redcare Pharmacy?
Navigating Market Challenges with New Leadership
This executive appointment comes at a critical juncture for Redcare Pharmacy as the company works to translate its European market leadership into a sustainable business model. The selection of a financial leader with deep expertise from digital commerce giants appears strategically calculated to address current challenges.
Redcare’s shares have faced significant pressure in recent months, trading near their 52-week low after declining substantially from their November 2024 peak of €170. Management anticipates that Krampe’s experience in managing complex e-commerce platforms will bring fresh perspective to capital allocation strategies, profitability enhancement, and investor communications.
The company’s strategic pivot under new financial leadership will be closely watched by market participants in the coming quarters, with investors keen to assess whether this management change can catalyze improved performance.
Ad
Redcare Pharmacy Stock: Buy or Sell?! New Redcare Pharmacy Analysis from November 11 delivers the answer:
The latest Redcare Pharmacy figures speak for themselves: Urgent action needed for Redcare Pharmacy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 11.
Redcare Pharmacy: Buy or sell? Read more here...









